Alain Baumann/wfhcongress2024; Panagiotis Christoforou/LinkedIn; Robert Klamroth/X
Aug 15, 2025, 03:44
Call for Global Action on Bleeding Disorders from Baumann, Christoforou and Klamroth
Kedrion Biopharma shared an insightful post on LiknedIn:
“Global voices on bleeding disorders: from awareness to action
At ISTH2025, we heard powerful insights from three leading voices in the bleeding disorders community, united by one mission: to close the gaps in diagnosis, awareness, and access to care.
- Alain Baumann, CEO of the World Federation of Hemophilia, reminded us that only 1 in 4 people with a bleeding disorder worldwide is diagnosed and treated. Women and girls, in particular, remain largely invisible in many systems of care.
- Dr. Panagiotis Christoforou, Steering Committee Member of EHC, called for stronger collaboration between patient associations, clinicians and policymakers, supported by shared data and transparent communication.
- Prof. Robert Klamroth, Head of Internal Medicine at Vivantes Clinic in Berlin, emphasized the critical role of education and clinical networking in improving early diagnosis and enabling access to new therapies for rare bleeding disorders.
Each voice highlights a different challenge, but together, they build a shared call to action.”
Watch the full video here.
Stay updated on the global initiatives in the World of Hematology with Hemostasis Today.
-
Oct 11, 2025, 09:06Natalia Peres Martinez - Surgical Bleed: Replacing Gut Feeling With Guided Thinking
-
Oct 11, 2025, 09:00Muhammad Ali - Hematology In Pakistan: The Silent Revolution In Diagnosis And A Blueprint For Growth
-
Oct 11, 2025, 08:50Robert Zeiser: New Insights and Timeless Lessons in Transplantation
-
Oct 11, 2025, 08:39Mildred Lundgren: These 5 Proposals Are A Clear Road Map for The Future And We Support Them Wholeheartedly
-
Oct 11, 2025, 08:33RPTH Journal: Does Fasting Affect Anticoagulant Therapy? - The Effects Of Fasting During Ramadan
-
Oct 11, 2025, 18:47Endovascular Today: SYMPHONY-PE Trial and Advances in Pulmonary Embolism Treatment
-
Oct 11, 2025, 08:49Rodrigo Assar: We Are Pushing the Boundaries by Using Computational Approaches
-
Oct 11, 2025, 08:48Deborah Wild: Thrilled to See GeneVentiv Selected for The NIH NHLBI Catalyze Program
-
Oct 11, 2025, 08:34Ivo Francischetti and Colleagues on Glycoprotein VI Contributing to Platelet Activation in HIT
-
Oct 11, 2025, 08:00Michael Hadley: Photon-Counting CT Offers Good Diagnostic Accuracy for Detecting In-Stent Restenosis
-
Oct 10, 2025, 12:25Robert Lewis: T Cells Are Wonderful - But They Can't Do Everything
-
Oct 9, 2025, 13:03Peter Graves: When the Bleeding Does Not Stop
-
Oct 8, 2025, 12:44Bobur Kholikov: Thrombosis Diagnostics with YHLO
-
Oct 7, 2025, 13:06Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 11, 2025, 08:57Jeff June - Seeing The Invisible: How Spatial Biology Is Opening A New Chapter In Stroke Care
-
Oct 11, 2025, 08:11Khaled Musallam: Honored to Be Featured for The 7th Year in A Row in The World’s Top 2% Most-Cited Scientists
-
Oct 11, 2025, 08:07Britta Diebel: This Has Been An Intense, Good Week, Although IPAW Actually Lasts All Year Long
-
Oct 10, 2025, 03:10Marilena Vrana: Plasma-Derived Medicines Are a Clear Example of Why A One-Size-Fits-All Approach Won’t Work
-
Oct 10, 2025, 03:07Nancy Di Salvo: It's IPAW 2025, How Could I Not Take a Moment to Thank Every Single Plasma Donor Out There?
Oct 11, 2025, 08:50
Oct 11, 2025, 08:44